Varicella supply resumes
March 6, 2014
GlaxoSmithKline (GSK)
has said shipments of varicella-containing
vaccines will resume
gradually by the end of February.
The company warned in January
that a “global manufacturing issue”
meant a temporary disruption in
supplies of Varilrix and Priorix-Tetra,
used to prevent chicken pox and
in the case of the latter, measles,
mumps and rubella as well (PD 29
Jan).
It said at the time that it was
working closely with State and
Federal Governments to manage
existing supplies of the vaccines
and to minimise the impact of the
disruption.
GSK said the vaccines did not pass
the release standard during testing,
and an investigation revealed that
there had been a leak in a bulk
container in its factory in Wavre,
Belgium.
The resumption of supply
followed an investigation and
resolution of the issue, including
corrective measures being put in
place at the manufacturing site to
help prevent the issue reoccurring,
GSK said.
The above article was sent to subscribers in Pharmacy Daily's issue from 06 Mar 14To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Mar 14
